DCF Advisers’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.12M Hold
172,500
1.45% 24
2025
Q1
$3.53M Buy
172,500
+83,100
+93% +$1.7M 1.69% 18
2024
Q4
$2.3M Buy
89,400
+55,400
+163% +$1.42M 1.11% 27
2024
Q3
$564K Buy
+34,000
New +$564K 0.23% 63